GP
CAH icon

Girard Partners’s Cardinal Health CAH Stock Holding History

Girard Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$285K Buy
2,900
+197
+7% +$20.1K 0.03% 223
2024
Q1 		$302K Sell
2,703
-175
-6% -$18.9K 0.03% 226
2023
Q4 		$290K Buy
2,878
+475
+20% +$47.1K 0.03% 216
2023
Q3 		$209K Hold
2,403
– – 0.02% 235
2023
Q2 		$227K Buy
+2,403
New +$203K 0.02% 237
2023
Q1 		– Sell
-2,627
Closed -$202K – 253
2022
Q4 		$202K Buy
+2,627
New +$200K 0.02% 256
2018
Q4 		– Sell
-5,944
Closed -$321K – 321
2018
Q3 		$321K Sell
5,944
-4,630
-44% -$237K 0.06% 191
2018
Q2 		$516K Sell
10,574
-9,959
-49% -$565K 0.1% 165
2018
Q1 		$1.29M Sell
20,533
-4,926
-19% -$338K 0.3% 85
2017
Q4 		$1.56M Sell
25,459
-13,725
-35% -$849K 0.3% 90
2017
Q3 		$2.62M Sell
39,184
-1,181
-3% -$83.5K 0.54% 59
2017
Q2 		$3.15M Buy
40,365
+3,284
+9% +$248K 0.68% 51
2017
Q1 		$3.02M Buy
37,081
+5,554
+18% +$437K 0.73% 47
2016
Q4 		$2.27M Buy
31,527
+3,595
+13% +$260K 0.66% 54
2016
Q3 		$2.17M Buy
27,932
+3,651
+15% +$295K 0.72% 50
2016
Q2 		$1.89M Buy
24,281
+7,148
+42% +$570K 0.72% 51
2016
Q1 		$1.4M Buy
17,133
+2,298
+15% +$187K 0.61% 55
2015
Q4 		$1.32M Buy
14,835
+2,180
+17% +$185K 0.64% 54
2015
Q3 		$972K Buy
12,655
+2,462
+24% +$206K 0.55% 65
2015
Q2 		$853K Buy
10,193
+117
+1% +$10.3K 0.48% 67
2015
Q1 		$910K Buy
10,076
+775
+8% +$66.7K 0.54% 63
2014
Q4 		$751K Buy
9,301
+3,421
+58% +$270K 0.47% 65
2014
Q3 		$441K Buy
5,880
+2,175
+59% +$158K 0.3% 86
2014
Q2 		$254K Buy
+3,705
New +$252K 0.18% 119

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Girard Partners's CAH Position: Q2 2024 in Review

Girard Partners increased its Cardinal Health (CAH) stake by 7.3% in Q2 2024, buying an estimated $20.1K and bringing the position to 2,900 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #223.

Girard Partners first reported a position in CAH in Q2 2014 and has held it in 24 quarters since. The position peaked at $3.15M in Q2 2017. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Girard Partners held 2,900 shares of Cardinal Health worth $285K as of Q2 2024.
  • Girard Partners bought 197 Cardinal Health shares in Q2 2024, an estimated $20.1K.
  • Cardinal Health made up 0.03% of Girard Partners's portfolio in Q2 2024, its #223 holding.
  • Girard Partners first reported a position in Cardinal Health in Q2 2014 and has held it in 24 quarters since.
  • Girard Partners's Cardinal Health position peaked at $3.15M in Q2 2017.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.